- •This is Single-center, retrospective study
- •Primary, primary-assisted and secondary patency rates at 12 months in our study were higher than for PTFE.
- •Bovine carotid artery graft is a good conduit of choice for dialysis access
The hemodialysis dependent population is increasing in the United States. Dialysis access complications are a significant source of morbidity and mortality for patients with end stage renal disease (ESRD). A surgically created autogenous arteriovenous fistula (AVF) has been the gold standard for dialysis access. However, for patients who are not candidates for AVF, arteriovenous grafts using various conduits have widely been utilized. In this study, we report the outcomes of bovine carotid artery (BCA) grafts for dialysis access at a single institution, and compare these results to those for polytetrafluoroethylene (PTFE) grafts.
A single-institution, retrospective review of all patients undergoing surgical placement of a bovine carotid artery graft for dialysis access from 2017-2018 was performed under an IRB-approved protocol. The primary, primary-assisted, and secondary patency were calculated for the whole cohort and results determined based on gender, BMI and indication for use. Comparison was performed to PTFE grafts at same institution from 2013 to 2016.
One hundred and twenty two patients were included in this study. Seventy-four patients had a BCA graft placed while 48 had a PTFE graft placed. . The mean age was 59.7±13.5 years in the BCA group, 55.8±14.5 in the PTFE group and the mean BMI was 29.8 ± 9.2 kg/m2 in the BCA group and 28.1±9.7 in the PTFE group. Comparison of the comorbidities present in BCA/PTFE groups included hypertension (92%/100%), diabetes (57%/54%), congestive heart failure (28%/10%), lupus (5%/7%), and chronic obstructive pulmonary disease (4%/8%). The various configurations were reviewed (BCA/PTFE): interposition/access salvage (40.5%/13%), axillary-axillary (18.9%/7%), brachial-basilic (5.4%,6%), brachial-brachial (4.1%,4%), brachial-cephalic (1.4%0%), axillary-brachial (1.4%/0%), brachial-axillary (23%, 62%), and femoral-femoral (5.4%,6%). Overall, twelve-month primary patency was 50% in the BCA group and 18% in the PTFE group (p=0.001). Twelve-month primary-assisted patency was 66% in the BCA group and 37% in the PTFE group (p=0.003). Twelve-month secondary patency was 81% in the BCA group and 36% in the PTFE group (p=0.07). When comparing BCA graft survival probability among male and female gender, males had better primary-assisted patency (p = 0.042). Secondary patency among the two genders was similar. There was no statistically significant difference in primary, primary-assisted and secondary patency of BCA grafts between different BMI groups or indication for use. The average patency of a bovine graft was 17.8 ±8 months. Sixty-one percent of the BCA grafts needed intervention with 24% needing multiple interventions. There was an average of 7 ±5 months to first intervention. The infection rate was 8.1% in the BCA group and 10.4% in the PTFE group with no statistical difference.
Primary and primary-assisted patency rates at 12 months in our study were higher than those for PTFE at our institution. There was higher primary assisted patency of BCA grafts among males at 12 months compared to PTFE. Obesity and indication for BCA graft use did not appear to affect patency in our population.
Abbreviations:BCA (Bovine Carotid Artery), ESRD (End Stage Renal Disease), IRB (Institutional Review Board), PTFE (Polytetrafluoroethylene), AVF (Arteriovenous Fistula), AVG (Arteriovenous Graft)
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Annals of Vascular Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
2019 USRDS Annual data report. https://www.usrds.org/2019/download/USRDS_2019_ES_final.pdf
- Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.Cardiovasc Eng Technol. 2017 Sep; 8: 244-254
End Stage Renal Disease (ESRD) National Coordinating Center (NCC): Fistula First Catheter Last—FFCL. Available at: http://esrdncc.org/ffcl/. Accessed May 8th, 2020.
- Clinical practice guidelines for vascular access.Am J Kidney Dis. 2006; 48: S176-S247
- Preoperative management of arteriovenous fistula (AVF) for hemodialysis.J Vasc Access. 2017; 18: 451-463
- Bovine heterografts for hemodialysis.West J Med. 1975; 123: 269-274
- Etiology and management of bovine graft aneurysms.Arch Surg. 1982; 117: 281-284
- A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access.Journal of Vascular Surgery. June 2011; 53: 1640-1648
- Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review.Journal of Vascular Surgery. November 2003; 38: 1005-1011
- Evidence-based data for the hemodialysis access surgeon.Semin Dial. 2004 May-Jun; 17: 217-223
- Equivalent outcomes with standard and heparin-bonded expanded polytetrafluoroethylene grafts used as conduits for hemodialysis access.Journal of Vascular Surgery. September 2016; 64: 715-718
- Vascular access for chronic hemodialysis using modified bovine arterial graft arteriovenous fistula.The American Journal of Surgery. July 1974; 128: 54-57
- Bovine artegraft arteriovenous fistulas for hemodialysis in one-hundred patients after “conventional” arteriovenous fistulas failed.Vascular and Endovascular Surgery. May 1976; 10: 169-175
- Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study.Am J Surg. 1983; 146: 844-847
- Arterio venous access utilizing modified bovine arterial grafts for hemodialysis.Annals of Surgery. 1977; 186: 643-650
- Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access.Journal of Vascular Surgery. March 2017; 65: 775-782
- Bovine carotid artery xenografts for hemodialysis access.Journal of Vascular Surgery. June 2017; 65: 1729-1734
- Impact of obesity on arteriovenous fistula outcomes in dialysis patients.Kidney International. 1 January 2007; 71: 39-43
- Obesity and hemodialysis vascular access failure.Am J Kidney Dis. 2007; 50: 450-454
- A Prospective Randomized Study of Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access.Journal of Vascular Surgery. 2018 May; 67: 1606-1612
- Early Cannulation of Bovine Carotid Artery Graft Reduces Tunneled Dialysis Catheter-Related Complications: A Comparison of Bovine Carotid Artery Graft Versus Expanded Polytetrafluoroethylene Grafts in Hemodialysis Access.Vascular Endovascular Surgery. 2019 Feb; 53: 104-111
- Patency in Arteriovenous Grafts in Hemodialysis Patients.Vasc Endovascular Surg. 2013 Aug; 47 (Mousa et al., 2013 22): 438-443
- The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts.J Vasc Surg. 2015 Nov; 62: 1258-1264
- Upper Arm Arteriovenous Grafts are Superior over Forearm Arteriovenous Grafts in Upper Extremity Dialysis Access.Ann Vasc Surg. 2020 Jul 29; : S0890-5096
Accepted: February 3, 2023
Received in revised form: February 1, 2023
Received: August 18, 2022
Publication stageIn Press Journal Pre-Proof
© 2023 Elsevier Inc. All rights reserved.